Better whole‑brain MR spectroscopy using a new coil and shimming approach
Unified Shim-RF Coil Technology for Improved Whole-Brain Spectroscopic MRI for Neurological Disorders
A new MRI coil and magnetic‑field correction method aims to produce clearer, contrast‑free brain chemical images for people with neurological conditions.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Weill Medical Coll of Cornell Univ NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11094086 on NIH RePORTER |
What this research studies
You would get brain scans using a redesigned RF coil and unified shimming system that reduces magnetic field distortions that blur spectroscopic images. The project combines hardware (a new coil) with fast 3D spectroscopic imaging methods to capture whole‑brain chemical maps at isotropic resolution. Because this method does not use gadolinium contrast, it avoids contrast‑related risks and focuses on metabolic information that standard MRI can miss. The team plans to implement the technology on clinical scanners and compare image quality across brain regions that are currently hard to image.
Who could benefit from this research
Good fit: Ideal candidates would include people with brain tumors, traumatic brain injury, suspected metabolic or neonatal brain disorders, demyelinating disease, or other neurological conditions where metabolic imaging could add information to standard MRI.
Not a fit: People with MRI‑incompatible implants, severe claustrophobia, or conditions unrelated to brain metabolism (or who specifically require gadolinium contrast for vascular imaging) may not benefit from this approach.
Why it matters
Potential benefit: If successful, this could provide clearer, whole‑brain metabolic images without contrast agents, helping diagnosis, surgical and radiation planning, and monitoring of many neurological conditions.
How similar studies have performed: Fast MRSI techniques like EPSI are already used and have shown promise regionally, but whole‑brain, isotropic‑resolution spectroscopic imaging that overcomes field‑inhomogeneity problems remains largely novel.
Where this research is happening
New York, United States
- Weill Medical Coll of Cornell Univ — New York, United States (Active)
Researchers
- Principal investigator: Ballon, Douglas J — Weill Medical Coll of Cornell Univ
- Study coordinator: Ballon, Douglas J
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.